Firuglipel, formerly known as DS-8500a, is an orally bioavailable G protein-coupled receptor 119 agonist. DS-8500a upregulates glucagon-like peptide-1 and enhances glucose-dependent insulin secretion and improves glucose homeostasis in type 2 diabetic rats. References: Matsumoto K, Yoshitomi T, Ishimoto Y, Tanaka N, Takahashi K, Watanabe A, Chiba K. DS-8500a, an Orally Available G Protein-Coupled Receptor 119 Agonist, Upregulates Glucagon-Like Peptide-1 and Enhances Glucose-Dependent Insulin Secretion and Improves Glucose Homeostasis in Type 2 Diabetic Rats. J Pharmacol Exp Ther. 2018 Dec;367(3):509-517. doi: 10.1124/jpet.118.250019. Epub 2018 Sep 14. PubMed PMID: 30217957.

纯度：≥98%

CAS：1371591-51-3